Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ozempic once weekly injection?Can lipitor reduce abdominal fat effectively?Should patients be aware of any additional muscle related precaut when using lipitor and warfar statins?Can a high fat diet increase lipitor's effectiveness?Is exercise performance hindered by lipitor?
See the DrugPatentWatch profile for yervoy
Yervoy Pricing and Rebates Yervoy, also known as ipilimumab, is an immune checkpoint inhibitor used to treat melanoma and other cancers [1]. The cost of Yervoy can be high, and patients may be eligible for discounts or rebates. However, there are certain restrictions on Yervoy discount programs. Manufacturer's Patient Assistance Program Bristol-Myers Squibb, the manufacturer of Yervoy, offers a patient assistance program that provides discounts on the medication. However, this program has eligibility criteria, and not all patients may qualify [2]. Patients must meet certain income and insurance criteria to be eligible. Insurance Coverage Insurance coverage for Yervoy can vary depending on the individual's insurance plan. Many insurance plans require patients to pay a significant copayment or coinsurance for Yervoy, which can range from 10% to 20% of the medication's cost [3]. Some patients may be required to try other treatments before Yervoy is covered. Generic or Biosimilar Options There are no generic or biosimilar versions of Yervoy available on the market, which can limit competition and drive up prices [4]. This has led to controversy over the high cost of Yervoy and the lack of affordable treatment options for patients. Patient Advocacy and Support Patients and advocacy groups have raised concerns about the high cost of Yervoy and the restrictions on discount programs. Some organizations offer financial assistance and support to patients in need of Yervoy treatment [5]. Sources: [1] Yervoy (ipilimumab) Label, Bristol-Myers Squibb (2022) [2] Patient Assistance Program, Bristol-Myers Squibb [3] National Average Cost, GoodRx (2022) [4] Biosimilars: Challenges and Opportunities, FDA (2022) [5] National Patient Advocate Foundation, (2022)
Other Questions About Yervoy :